Nymox Pharmaceutical Corporation
NYMXF
$0.0751
-$0.0049-6.13%
OTC PK
12/31/2024 | 12/31/2023 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 80.49% | -7.89% | -7.89% | -42.42% | -62.39% |
Total Receivables | 17.39% | 57.14% | 57.14% | -30.00% | 0.00% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -30.43% | -97.05% | -97.05% | 1,134.09% | -38.89% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 0.00% | 1,785.71% | 1,785.71% | 0.00% | 0.00% |
Total Current Assets | 4.82% | -4.43% | -4.43% | 205.61% | -53.58% |
|
|||||
Total Current Assets | 4.82% | -4.43% | -4.43% | 205.61% | -53.58% |
Net Property, Plant & Equipment | 0.00% | -86.67% | -86.67% | -73.68% | -50.00% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 4.81% | -6.28% | -6.28% | 146.86% | -52.87% |
|
|||||
Total Accounts Payable | -4.61% | 18.09% | 18.09% | 9.26% | 3.67% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | 26.09% | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -80.00% | -51.75% |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 7.36% | 47.80% | 47.80% | -18.33% | 32.60% |
|
|||||
Total Current Liabilities | 7.36% | 47.80% | 47.80% | -18.33% | 32.60% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 26.09% | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 7.36% | 47.80% | 47.80% | -18.33% | 32.60% |
|
|||||
Common Stock & APIC | 0.14% | 0.41% | 0.41% | 1.01% | 0.02% |
Retained Earnings | -0.40% | -2.62% | -2.62% | -0.51% | -0.55% |
Treasury Stock & Other | 2.42% | -- | -- | -- | -- |
Total Common Equity | -7.61% | -66.82% | -66.82% | 33.89% | -59.92% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -7.61% | -66.82% | -66.82% | 33.89% | -59.92% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -7.61% | -66.82% | -66.82% | 33.89% | -59.92% |
|